Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Gastrointestinal 1

Conditions

Obesity 23Polycystic Ovary Syndrome 17Breast Neoplasms 3Weight Loss 2Overweight 2Insulin Resistance 2Infertility, Female 2Diabetes, Gestational 2Diabetes Mellitus 2Pregnancy Complications 1Prediabetic State 1Obesity, Morbid 1Neoplasms 1Motor Activity 1Lipid Metabolism Disorders 1Infertility 1Hyperinsulinism 1Diabetes Mellitus, Type 2 1Colorectal Neoplasms 1Cardiovascular Diseases 1Adenomatous Polyps 1

Interventions

Metformin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Adenomatous Polyps × Metformin × Other × Clear all
NCT01312467 2019-03-05

Trial of Metformin for Colorectal Cancer Risk Reduction for History of Colorectal Adenomas and Elevated BMI

National Cancer Institute (NCI)

Phase 2 Completed
45 enrolled 7 charts
GastrointestinalOther

Obesity, Colorectal Neoplasms, Adenomatous Polyps

Data powered by HemOnc (CC BY 4.0) Colophon âš¡